Inflammation and Cardiovascular Disease Risk: A Case Study of HIV and Inflammatory Joint Disease

Faisal Rahman, Seth Martin, Seamus Whelton, Freny V. Mody, Joban Vaishnav, John William McEvoy

Research output: Contribution to journalArticle

Abstract

The epidemiologic data associating infection and inflammation with increased risk of cardiovascular disease is well established. Patients with chronically upregulated inflammatory pathways, such as those with HIV and inflammatory joint diseases, often have a risk of future cardiovascular risk that is similar to or higher than patients with diabetes. Thus, it is of heightened importance for clinicians to consider the cardiovascular risk of patients with these conditions. HIV and inflammatory joint diseases are archetypal examples of how inflammatory disorders contribute to vascular disease and provide illustrative lessons that can be leveraged in the prevention of cardiovascular disease. Managing chronic inflammatory diseases calls for a multifaceted approach to evaluation and treatment of suboptimal lifestyle habits, accurate estimation of cardiovascular disease risk with potential upwards recalibration due to chronic inflammation, and more intensive treatment of risk factors because current tools often underestimate the risk in this population. This approach is further supported by the recently published CANTOS trial demonstrating that reducing inflammation can serve as a therapeutic target among persons with residual inflammatory risk for cardiovascular disease.

Original languageEnglish (US)
JournalAmerican Journal of Medicine
DOIs
StateAccepted/In press - Jan 1 2018

Keywords

  • Cardiovascular disease
  • Human immunodeficiency virus
  • Inflammatory joint diseases
  • Prevention
  • Risk

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Inflammation and Cardiovascular Disease Risk: A Case Study of HIV and Inflammatory Joint Disease'. Together they form a unique fingerprint.

Cite this